
LeMaitre Vascular LMAT
$ 92.49
0.58%
Quarterly report 2026-Q1
added 05-06-2026
LeMaitre Vascular DIO Ratio 2011-2026 | LMAT
Annual DIO Ratio LeMaitre Vascular
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 338 | 295 | 233 | 236 | 229 | 269 | 249 | 250 | 167 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 338 | 167 | 252 |
Quarterly DIO Ratio LeMaitre Vascular
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 129 | 227 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 227 | 129 | 178 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
213 | $ 68.06 | 0.27 % | $ 13.6 B | ||
|
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | ||
|
Glaukos Corporation
GKOS
|
198 | $ 129.02 | 1.74 % | $ 7.38 B | ||
|
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
126 | $ 66.67 | -0.27 % | $ 40.4 B | ||
|
Intuitive Surgical
ISRG
|
177 | $ 416.46 | 1.31 % | $ 149 B | ||
|
ICU Medical
ICUI
|
155 | $ 144.87 | 1.87 % | $ 3.57 B | ||
|
iRhythm Technologies
IRTC
|
29.6 | $ 114.48 | 0.73 % | $ 3.66 B | ||
|
Repro Med Systems
KRMD
|
76.2 | $ 4.0 | - | $ 185 M | ||
|
Masimo Corporation
MASI
|
168 | $ 179.95 | - | $ 9.59 B | ||
|
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | ||
|
Merit Medical Systems
MMSI
|
150 | $ 67.16 | 0.95 % | $ 3.97 B | ||
|
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
288 | - | - | $ 28.6 M | ||
|
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | ||
|
Milestone Scientific
MLSS
|
533 | $ 0.36 | 1.94 % | $ 29.5 M | ||
|
electroCore
ECOR
|
142 | $ 9.92 | -3.22 % | $ 84.2 K | ||
|
Envista Holdings Corporation
NVST
|
78.3 | $ 25.05 | 1.83 % | $ 4.21 B | ||
|
Haemonetics Corporation
HAE
|
224 | $ 77.62 | -0.74 % | $ 3.66 B | ||
|
Isoray
ISR
|
159 | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
66.9 | $ 207.0 | -0.27 % | $ 20.3 B | ||
|
STAAR Surgical Company
STAA
|
164 | $ 28.82 | 1.59 % | $ 1.43 B | ||
|
InfuSystem Holdings
INFU
|
34.5 | $ 8.91 | -2.73 % | $ 184 M | ||
|
Teleflex Incorporated
TFX
|
149 | $ 130.98 | 0.38 % | $ 5.84 B | ||
|
West Pharmaceutical Services
WST
|
76 | $ 329.62 | 0.24 % | $ 23.8 B | ||
|
Utah Medical Products
UTMD
|
185 | $ 69.83 | 2.93 % | $ 226 M | ||
|
Pulse Biosciences
PLSE
|
46 | $ 25.92 | 6.36 % | $ 1.75 B | ||
|
DENTSPLY SIRONA
XRAY
|
120 | $ 10.22 | 1.24 % | $ 2.04 B | ||
|
Retractable Technologies
RVP
|
174 | $ 0.69 | -1.23 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
145 | $ 62.48 | 0.45 % | $ 205 M | ||
|
Predictive Oncology
POAI
|
115 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
317 | $ 26.87 | 2.94 % | $ 1.28 B | ||
|
Stereotaxis
STXS
|
213 | $ 1.87 | 1.63 % | $ 170 M | ||
|
Baxter International
BAX
|
99.3 | $ 21.08 | 1.05 % | $ 10.8 B | ||
|
ResMed
RMD
|
141 | $ 194.3 | -0.25 % | $ 28.4 B | ||
|
AtriCure
ATRC
|
210 | $ 28.57 | -0.78 % | $ 1.36 B | ||
|
Harvard Bioscience
HBIO
|
219 | $ 6.02 | -0.99 % | $ 267 M | ||
|
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
166 | $ 12.13 | 0.25 % | $ 496 M | ||
|
Becton, Dickinson and Company
BDX
|
119 | $ 146.78 | 0.37 % | $ 42.2 B | ||
|
Nephros
NEPH
|
149 | $ 3.34 | -0.15 % | $ 35.4 M | ||
|
OraSure Technologies
OSUR
|
178 | $ 4.18 | -0.12 % | $ 307 M | ||
|
Repligen Corporation
RGEN
|
162 | $ 133.62 | 2.32 % | $ 7.51 M |